This is a community-generated profile. If you would like to claim it, please .
HistoSonics Funding
$0
33 rounds
HistoSonics is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on December 15, 2022.
Investors of HistoSonics
Nikita Kulkarni
14+ years of healthcare experience in investment banking, venture investing, and R&D
Daniel van der Weide
Professor ECE UW Madison
Stanford PhD EE 1993
Optametra (sold to Tektronix 2011)
NeuWave Medical (sold to J&J 2016)
Elucent Medical (board member)
Grand Rapids Business Journal
TGap Ventures
Fletcher Spaght Ventures
Wolverine Venture Fund
Hatteras Venture Partners
Grand Angels
Early Stage Partners
